Junior Regulatory Affairs in Medtech (50% or more) (F/M)

Decomplix simplifies market access for medical devices. As a legal manufacturer and Swiss Authorized Representative, Decomplix goes beyond consulting and assumes pre- and post-market responsibility. In times of more stringent regulatory hurdles, this business model provides Decomplix customers with legal protection, lower risks and shorter time-to-market. Quality management and regulatory affairs are our core competence. For the expansion of our core team, we are looking for a Junior Regulatory Affairs in Medtech (50% or more) (F/M)

You take on

  • contribution to the regulatory affairs services we provide to customers on their pre and post-market phases;
  • regulatory support to internal initiatives to improve our services;
  • regulatory monitoring of the applicable legislation, mostly in EEA countries and Switzerland.

You bring

  • a scientific or technical background;
  • an initial professional experience in the Medtech industry, preferably in quality management or regulatory affairs or medical device design & development;
  • the ability to quickly grasp, generalize and synthesize complex technical concepts, and make them easily understandable in text and pictures;
  • attention to detail and customer focus;
  • good knowledge of German and English, spoken and written.

You want

  • to expand your regulatory affairs competence, by working with various companies and products;
  • to work independently, entrepreneurially and also take on new tasks;
  • to contribute to the improvement of patients’ health with medical devices.

You get the chance,

  • to be part of a growing company with a unique business model;
  • to develop yourself in regulatory affairs with our team;
  • to adapt constantly and quickly to new products, processes, and projects;
  • to work in a flat structure and with flexible working hours in Bern and remotely.

Interested? We would like to get to know you. Send us your application file by e-mail to Beni Hirt, work@decomplix.com.


More articles